Te Ara Waiora–Implementing human papillomavirus (HPV) primary testing to prevent cervical cancer in Aotearoa New Zealand: A protocol for a non-inferiority trial
<h4>Background</h4> Cervical cancer is caused by high-risk types of human papillomavirus (HPV). Testing for high-risk HPV is a more sensitive screening method than cervical cytology for detecting cervical changes that may lead to cancer. Consistent with recent evidence of efficacy and acceptability,...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science (PLoS)
2023-01-01
|
| Collection: | PLoS ONE |
| Accès en ligne: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10035917/?tool=EBI |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
